首页> 外文期刊>Minimally invasive therapy and allied technologies: MITAT : official journal of the Society for Minimally Invasive Therapy >Evaluation of the novel bipolar vessel sealing and cutting device BiCision? in a porcine model
【24h】

Evaluation of the novel bipolar vessel sealing and cutting device BiCision? in a porcine model

机译:新型双极血管封切装置BiCision的评估?在猪模型中

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Energy-based technologies for tissue sealing and cutting are increasingly supplementing current standards used for haemostasis and dissection during laparoscopic surgery. For their safe and efficacious use in clinical practice, these instruments have to guarantee sufficient burst resistance and low thermal damage to adjacent tissue in combination with good cutting characteristics. Material and methods: The novel laparoscopic, bipolar electrosurgical sealing and cutting instrument BiCision? was compared to a commercially available laparoscopic device (EnSeal?) on visceral and peripheral arteries and veins in an animal model. Results: For all parameters investigated (burst pressure, cut quality, tissue adhering to the instrument, time needed to seal and cut the vessel and thermal damage), BiCision? was at least as good as EnSeal?. Regarding the burst pressure, BiCision? was superior over EnSeal? in arteries: 600 mmHg (±478) versus 241 (±269) mmHg, respectively (p 0.0001*). In veins, almost equivalent burst pressures of 155 ± 134 mmHg (BiCision?) and 173 ± 139 mmHg (EnSeal?) were obtained. Conclusion: BiCision? appeared to be as good as or even superior to EnSeal?. Since EnSeal? has already been shown to be safe and has been successfully used in clinical practice, BiCision? is assumed to be as efficient and reliable as EnSeal ? under pre-clinical conditions.
机译:背景:基于能量的组织密封和切割技术正日益补充当前用于腹腔镜手术止血和解剖的标准。为了在临床实践中安全有效地使用这些仪器,必须保证足够的耐破裂性和对相邻组织的低热损伤以及良好的切割特性。材料和方法:新型腹腔镜,双极电外科密封切割器械BiCision?在动物模型的内脏和外周动脉和静脉上,将其与市售腹腔镜装置(EnSeal?)进行比较。结果:对于所有调查的参数(爆破压力,切割质量,粘附在仪器上的组织,密封和切割血管所需的时间以及热损伤),BiCision?至少和EnSeal一样好?关于爆破压力,BiCision?比EnSeal优越?在动脉中:分别为600 mmHg(±478)和241(±269)mmHg(p <0.0001 *)。在静脉中,获得几乎相等的爆破压力,分别为155±134 mmHg(BiCision?)和173±139 mmHg(EnSeal?)。结论:BiCision?似乎与EnSeal一样好甚至更好。自从EnSeal以来?已经被证明是安全的,并已在临床实践中成功使用BiCision?是否假定与EnSeal一样有效和可靠?在临床前条件下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号